✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Vaishali Pharma Ltd.

VAISHALI

Market Cap
₹164 Cr.
P/E
200.24

Vaishali Pharma Ltd.

  • Vaishali Pharma
  • Bal Pharma
  • IndoAmerican Advance
FAQs on Vaishali Pharma Ltd. Shareprice

Vaishali Pharma has given better returns compared to its competitors.
Vaishali Pharma has grown at ~33.47% over the last 6yrs while peers have grown at a median rate of 7.0%

Yes, Vaishali Pharma is expensive.
Latest PE of Vaishali Pharma is 199, while 3 year average PE is 89.69.
Also latest EV/EBITDA of Vaishali Pharma is 1941 while 3yr average is 93.58.

View FAQ's On Business
Growth Table
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Balance Sheet
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Cash Flow
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Quarterly Results
  • Vaishali Pharma Ltd.
  • Bal Pharma
  • IndoAmerican Advance
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vaishali Pharma Ltd. Financials

Balance sheet of Vaishali Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Vaishali Pharma is increasing.
Latest net debt of Vaishali Pharma is ₹9.82 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹9.62 Crs.

The profit is oscillating.
The profit of Vaishali Pharma is ₹0.82 Crs for TTM, ₹0.72 Crs for Mar 2024 and ₹6.6 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vaishali Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech